BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9456122)

  • 1. "Incomplete resection" in non-small cell lung cancer: need for a new definition. Canadian Lung Oncology Group.
    Lacasse Y; Bucher HC; Wong E; Griffith L; Walter S; Ginsberg RJ; Guyatt GH
    Ann Thorac Surg; 1998 Jan; 65(1):220-6. PubMed ID: 9456122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Surgical management of non-small-cell lung cancer with ipsilateral mediastinal node metastasis (N2 disease).
    Goldstraw P; Mannam GC; Kaplan DK; Michail P
    J Thorac Cardiovasc Surg; 1994 Jan; 107(1):19-27; discussion 27-8. PubMed ID: 8283883
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical outcomes after initial surgery for clinical single-station N2 non-small-cell lung cancer.
    Hishida T; Yoshida J; Ohe Y; Aokage K; Ishii G; Nagai K
    Jpn J Clin Oncol; 2014 Jan; 44(1):85-92. PubMed ID: 24203815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodal stage of surgically resected non-small cell lung cancer and its effect on recurrence patterns and overall survival.
    Varlotto JM; Yao AN; DeCamp MM; Ramakrishna S; Recht A; Flickinger J; Andrei A; Reed MF; Toth JW; Fizgerald TJ; Higgins K; Zheng X; Shelkey J; Medford-Davis LN; Belani C; Kelsey CR
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):765-73. PubMed ID: 25752390
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Results of surgical intervention for p-stage IIIA (N2) non-small cell lung cancer: acceptable prognosis predicted by complete resection in patients with single N2 disease with primary tumor in the upper lobe.
    Inoue M; Sawabata N; Takeda S; Ohta M; Ohno Y; Maeda H
    J Thorac Cardiovasc Surg; 2004 Apr; 127(4):1100-6. PubMed ID: 15052208
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bronchial resection margin length and clinical outcome in non-small cell lung cancer.
    Tomaszek SC; Kim Y; Cassivi SD; Jensen MR; Shen KH; Nichols FC; Deschamps C; Wigle DA
    Eur J Cardiothorac Surg; 2011 Nov; 40(5):1151-6. PubMed ID: 21450488
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Border between N1 and N2 stations in lung carcinoma: lessons from lymph node metastatic patterns of lower lobe tumors.
    Okada M; Sakamoto T; Yuki T; Mimura T; Nitanda H; Miyoshi K; Tsubota N
    J Thorac Cardiovasc Surg; 2005 Apr; 129(4):825-30. PubMed ID: 15821650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mediastinoscopy might not be necessary in patients with non-small cell lung cancer with mediastinal lymph nodes having a maximum standardized uptake value of less than 5.3.
    Lee BE; Redwine J; Foster C; Abella E; Lown T; Lau D; Follette D
    J Thorac Cardiovasc Surg; 2008 Mar; 135(3):615-9. PubMed ID: 18329480
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic significance of surgical-pathologic N1 disease in non-small cell carcinoma of the lung.
    Riquet M; Manac'h D; Le Pimpec-Barthes F; Dujon A; Chehab A
    Ann Thorac Surg; 1999 Jun; 67(6):1572-6. PubMed ID: 10391257
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: results of mediastinal staging in the early lung positron emission tomography trial.
    Darling GE; Maziak DE; Inculet RI; Gulenchyn KY; Driedger AA; Ung YC; Gu CS; Kuruvilla MS; Cline KJ; Julian JA; Evans WK; Levine MN
    J Thorac Oncol; 2011 Aug; 6(8):1367-72. PubMed ID: 21587082
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk Factors for Local and Distant Recurrence After Surgical Treatment in Patients With Non-Small-Cell Lung Cancer.
    Dziedzic DA; Rudzinski P; Langfort R; Orlowski T;
    Clin Lung Cancer; 2016 Sep; 17(5):e157-e167. PubMed ID: 26831834
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Surgical multimodality treatment for baseline resectable stage IIIA-N2 non-small cell lung cancer. Degree of mediastinal lymph node involvement and impact on survival.
    Decaluwé H; De Leyn P; Vansteenkiste J; Dooms C; Van Raemdonck D; Nafteux P; Coosemans W; Lerut T
    Eur J Cardiothorac Surg; 2009 Sep; 36(3):433-9. PubMed ID: 19502079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of surgical adjuvant thoracic radiation therapy for patients with nonsmall cell lung carcinoma with ipsilateral mediastinal lymph node involvement.
    Sawyer TE; Bonner JA; Gould PM; Foote RL; Deschamps C; Trastek VF; Pairolero PC; Allen MS; Shaw EG; Marks RS; Frytak S; Lange CM; Li H
    Cancer; 1997 Oct; 80(8):1399-408. PubMed ID: 9338463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systematic nodal dissection in the intrathoracic staging of patients with non-small cell lung cancer.
    Graham AN; Chan KJ; Pastorino U; Goldstraw P
    J Thorac Cardiovasc Surg; 1999 Feb; 117(2):246-51. PubMed ID: 9918964
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
    Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
    Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Results of resection of T3 non-small cell lung cancer invading the mediastinum or main bronchus.
    Pitz CC; Brutel de la Rivière A; Elbers HR; Westermann CJ; van den Bosch JM
    Ann Thorac Surg; 1996 Oct; 62(4):1016-20. PubMed ID: 8823082
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Morbidity, survival, and site of recurrence after mediastinal lymph-node dissection versus systematic sampling after complete resection for non-small cell lung cancer.
    Lardinois D; Suter H; Hakki H; Rousson V; Betticher D; Ris HB
    Ann Thorac Surg; 2005 Jul; 80(1):268-74; discussion 274-5. PubMed ID: 15975380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of surgical-pathologic multiple-station N1 disease in non-small cell carcinoma of the lung.
    Sayar A; Turna A; Kiliçgün A; Solak O; Urer N; Gürses A
    Eur J Cardiothorac Surg; 2004 Mar; 25(3):434-8. PubMed ID: 15019674
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sublobar Resection Margin Width Does Not Affect Recurrence of Clinical N0 Non-small Cell Lung Cancer Presenting as GGO-Predominant Nodule of 3 cm or Less.
    Moon Y; Lee KY; Moon SW; Park JK
    World J Surg; 2017 Feb; 41(2):472-479. PubMed ID: 27718002
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Surgery for non-small cell lung cancer with unsuspected metastasis to ipsilateral mediastinal or subcarinal nodes (N2 disease).
    De Leyn P; Schoonooghe P; Deneffe G; Van Raemdonck D; Coosemans W; Vansteenkiste J; Lerut T
    Eur J Cardiothorac Surg; 1996; 10(8):649-54; discussion 654-5. PubMed ID: 8875173
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.